nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—colon cancer	0.4	0.767	CbGaD
Lidocaine—ABCB1—colon cancer	0.121	0.233	CbGaD
Lidocaine—CYP2A6—Fluorouracil—colon cancer	0.0388	0.119	CbGbCtD
Lidocaine—CYP3A7—Irinotecan—colon cancer	0.0276	0.0851	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0276	0.0851	CbGbCtD
Lidocaine—CYP2B6—Irinotecan—colon cancer	0.0263	0.081	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0242	0.0743	CbGbCtD
Lidocaine—CYP3A7—Vincristine—colon cancer	0.0242	0.0743	CbGbCtD
Lidocaine—CYP2C9—Capecitabine—colon cancer	0.0225	0.0693	CbGbCtD
Lidocaine—CYP3A5—Irinotecan—colon cancer	0.0207	0.0638	CbGbCtD
Lidocaine—CYP2C8—Fluorouracil—colon cancer	0.0191	0.0589	CbGbCtD
Lidocaine—CYP3A5—Vincristine—colon cancer	0.0181	0.0558	CbGbCtD
Lidocaine—CYP1A2—Fluorouracil—colon cancer	0.0148	0.0456	CbGbCtD
Lidocaine—ABCB1—Irinotecan—colon cancer	0.0135	0.0415	CbGbCtD
Lidocaine—CYP2C9—Fluorouracil—colon cancer	0.0133	0.0411	CbGbCtD
Lidocaine—ABCB1—Vincristine—colon cancer	0.0118	0.0363	CbGbCtD
Lidocaine—CYP3A4—Irinotecan—colon cancer	0.00809	0.0249	CbGbCtD
Lidocaine—ABCB1—Methotrexate—colon cancer	0.00714	0.022	CbGbCtD
Lidocaine—CYP3A4—Vincristine—colon cancer	0.00707	0.0217	CbGbCtD
Lidocaine—Cranial nerve paralysis—Vincristine—colon cancer	0.00561	0.0629	CcSEcCtD
Lidocaine—Cranial nerve paralysis—Methotrexate—colon cancer	0.00272	0.0305	CcSEcCtD
Lidocaine—CNS toxicity—Methotrexate—colon cancer	0.00272	0.0305	CcSEcCtD
Lidocaine—Meningism—Methotrexate—colon cancer	0.00181	0.0203	CcSEcCtD
Lidocaine—Arachnoiditis—Methotrexate—colon cancer	0.00172	0.0193	CcSEcCtD
Lidocaine—Neurotoxicity—Vincristine—colon cancer	0.00167	0.0187	CcSEcCtD
Lidocaine—Hypoaesthesia oral—Capecitabine—colon cancer	0.00162	0.0181	CcSEcCtD
Lidocaine—Skin irritation—Fluorouracil—colon cancer	0.0014	0.0156	CcSEcCtD
Lidocaine—Slurred speech—Fluorouracil—colon cancer	0.00135	0.0151	CcSEcCtD
Lidocaine—Application site reaction—Fluorouracil—colon cancer	0.00129	0.0144	CcSEcCtD
Lidocaine—Shivering—Capecitabine—colon cancer	0.00113	0.0127	CcSEcCtD
Lidocaine—Local reaction—Fluorouracil—colon cancer	0.00109	0.0122	CcSEcCtD
Lidocaine—Neurotoxicity—Capecitabine—colon cancer	0.00109	0.0122	CcSEcCtD
Lidocaine—Taste metallic—Methotrexate—colon cancer	0.000987	0.0111	CcSEcCtD
Lidocaine—Hoarseness—Capecitabine—colon cancer	0.000959	0.0107	CcSEcCtD
Lidocaine—Paralysis—Vincristine—colon cancer	0.000931	0.0104	CcSEcCtD
Lidocaine—Paraesthesia oral—Capecitabine—colon cancer	0.000899	0.0101	CcSEcCtD
Lidocaine—Blister—Fluorouracil—colon cancer	0.000837	0.00938	CcSEcCtD
Lidocaine—Neurotoxicity—Methotrexate—colon cancer	0.00081	0.00908	CcSEcCtD
Lidocaine—Numbness—Vincristine—colon cancer	0.000781	0.00875	CcSEcCtD
Lidocaine—Sensory loss—Vincristine—colon cancer	0.000747	0.00837	CcSEcCtD
Lidocaine—Leukoderma—Methotrexate—colon cancer	0.000739	0.00828	CcSEcCtD
Lidocaine—Numbness—Fluorouracil—colon cancer	0.000728	0.00816	CcSEcCtD
Lidocaine—Sensory loss—Fluorouracil—colon cancer	0.000697	0.00781	CcSEcCtD
Lidocaine—Tenderness—Fluorouracil—colon cancer	0.000692	0.00775	CcSEcCtD
Lidocaine—Dysarthria—Irinotecan—colon cancer	0.000666	0.00747	CcSEcCtD
Lidocaine—Dysarthria—Fluorouracil—colon cancer	0.000638	0.00715	CcSEcCtD
Lidocaine—SCN4A—renal system—colon cancer	0.000615	0.0424	CbGeAlD
Lidocaine—Neuropathy—Vincristine—colon cancer	0.000608	0.00681	CcSEcCtD
Lidocaine—Dermatitis contact—Fluorouracil—colon cancer	0.000596	0.00669	CcSEcCtD
Lidocaine—CYP2C18—digestive system—colon cancer	0.000594	0.0409	CbGeAlD
Lidocaine—Coma—Vincristine—colon cancer	0.000591	0.00663	CcSEcCtD
Lidocaine—Blister—Capecitabine—colon cancer	0.000585	0.00656	CcSEcCtD
Lidocaine—Throat sore—Capecitabine—colon cancer	0.000585	0.00656	CcSEcCtD
Lidocaine—Oropharyngeal discomfort—Capecitabine—colon cancer	0.00058	0.0065	CcSEcCtD
Lidocaine—Coma—Fluorouracil—colon cancer	0.000552	0.00618	CcSEcCtD
Lidocaine—Ventricular fibrillation—Capecitabine—colon cancer	0.000551	0.00617	CcSEcCtD
Lidocaine—Hyperaesthesia—Capecitabine—colon cancer	0.000537	0.00602	CcSEcCtD
Lidocaine—CYP2C18—vagina—colon cancer	0.000524	0.0362	CbGeAlD
Lidocaine—Euphoric mood—Fluorouracil—colon cancer	0.000519	0.00581	CcSEcCtD
Lidocaine—Petechiae—Capecitabine—colon cancer	0.000513	0.00575	CcSEcCtD
Lidocaine—Dysphonia—Capecitabine—colon cancer	0.000513	0.00575	CcSEcCtD
Lidocaine—EGFR—liver—colon cancer	0.000512	0.0353	CbGeAlD
Lidocaine—Disorientation—Fluorouracil—colon cancer	0.00049	0.00549	CcSEcCtD
Lidocaine—Contusion—Capecitabine—colon cancer	0.000483	0.00542	CcSEcCtD
Lidocaine—Visual disturbance—Irinotecan—colon cancer	0.000483	0.00541	CcSEcCtD
Lidocaine—SCN3A—renal system—colon cancer	0.000479	0.033	CbGeAlD
Lidocaine—Anaphylactoid reaction—Irinotecan—colon cancer	0.000473	0.0053	CcSEcCtD
Lidocaine—Oropharyngeal pain—Capecitabine—colon cancer	0.000464	0.0052	CcSEcCtD
Lidocaine—Dermatitis bullous—Fluorouracil—colon cancer	0.000458	0.00514	CcSEcCtD
Lidocaine—Osteoarthritis—Irinotecan—colon cancer	0.000457	0.00513	CcSEcCtD
Lidocaine—Paralysis—Methotrexate—colon cancer	0.000452	0.00506	CcSEcCtD
Lidocaine—Burning sensation—Methotrexate—colon cancer	0.000452	0.00506	CcSEcCtD
Lidocaine—Cardiac arrest—Vincristine—colon cancer	0.000447	0.00501	CcSEcCtD
Lidocaine—Urinary retention—Vincristine—colon cancer	0.000447	0.00501	CcSEcCtD
Lidocaine—Dysarthria—Capecitabine—colon cancer	0.000446	0.005	CcSEcCtD
Lidocaine—CYP2C18—liver—colon cancer	0.000442	0.0305	CbGeAlD
Lidocaine—Osteoarthritis—Fluorouracil—colon cancer	0.000438	0.00491	CcSEcCtD
Lidocaine—SCN10A—lymphoid tissue—colon cancer	0.000436	0.0301	CbGeAlD
Lidocaine—Cardiac arrest—Irinotecan—colon cancer	0.000435	0.00488	CcSEcCtD
Lidocaine—CYP3A7—liver—colon cancer	0.000421	0.029	CbGeAlD
Lidocaine—Cardiac arrest—Fluorouracil—colon cancer	0.000417	0.00467	CcSEcCtD
Lidocaine—Urinary incontinence—Capecitabine—colon cancer	0.000407	0.00456	CcSEcCtD
Lidocaine—Depressed level of consciousness—Capecitabine—colon cancer	0.000407	0.00456	CcSEcCtD
Lidocaine—Skin exfoliation—Capecitabine—colon cancer	0.000403	0.00451	CcSEcCtD
Lidocaine—Gingivitis—Methotrexate—colon cancer	0.0004	0.00448	CcSEcCtD
Lidocaine—Neuropathy—Capecitabine—colon cancer	0.000396	0.00444	CcSEcCtD
Lidocaine—SCN2A—vagina—colon cancer	0.000394	0.0272	CbGeAlD
Lidocaine—EGFR—lymph node—colon cancer	0.000392	0.0271	CbGeAlD
Lidocaine—SCN5A—digestive system—colon cancer	0.000391	0.027	CbGeAlD
Lidocaine—Sweating increased—Irinotecan—colon cancer	0.000385	0.00432	CcSEcCtD
Lidocaine—Petechiae—Methotrexate—colon cancer	0.000382	0.00428	CcSEcCtD
Lidocaine—Dysphagia—Fluorouracil—colon cancer	0.000379	0.00424	CcSEcCtD
Lidocaine—Apnoea—Methotrexate—colon cancer	0.00037	0.00415	CcSEcCtD
Lidocaine—SCN3A—bone marrow—colon cancer	0.000362	0.025	CbGeAlD
Lidocaine—CYP3A7-CYP3A51P—liver—colon cancer	0.000358	0.0247	CbGeAlD
Lidocaine—Neuropathy peripheral—Vincristine—colon cancer	0.000355	0.00398	CcSEcCtD
Lidocaine—Stomatitis—Vincristine—colon cancer	0.000353	0.00395	CcSEcCtD
Lidocaine—SCN3A—vagina—colon cancer	0.000347	0.0239	CbGeAlD
Lidocaine—CYP2A6—vagina—colon cancer	0.000346	0.0239	CbGeAlD
Lidocaine—SCN5A—vagina—colon cancer	0.000346	0.0238	CbGeAlD
Lidocaine—Stomatitis—Irinotecan—colon cancer	0.000344	0.00385	CcSEcCtD
Lidocaine—Dysarthria—Methotrexate—colon cancer	0.000332	0.00372	CcSEcCtD
Lidocaine—Neuropathy peripheral—Fluorouracil—colon cancer	0.000331	0.00371	CcSEcCtD
Lidocaine—Stomatitis—Fluorouracil—colon cancer	0.000329	0.00369	CcSEcCtD
Lidocaine—Hypoaesthesia—Vincristine—colon cancer	0.000323	0.00362	CcSEcCtD
Lidocaine—SCN9A—lymph node—colon cancer	0.000323	0.0223	CbGeAlD
Lidocaine—Bradycardia—Irinotecan—colon cancer	0.000322	0.00361	CcSEcCtD
Lidocaine—Dermatitis bullous—Capecitabine—colon cancer	0.00032	0.00359	CcSEcCtD
Lidocaine—Haemoglobin—Irinotecan—colon cancer	0.000318	0.00356	CcSEcCtD
Lidocaine—Rhinitis—Irinotecan—colon cancer	0.000317	0.00356	CcSEcCtD
Lidocaine—Haemorrhage—Irinotecan—colon cancer	0.000316	0.00355	CcSEcCtD
Lidocaine—Osteoarthritis—Capecitabine—colon cancer	0.000306	0.00343	CcSEcCtD
Lidocaine—Diplopia—Capecitabine—colon cancer	0.000306	0.00343	CcSEcCtD
Lidocaine—Visual impairment—Irinotecan—colon cancer	0.000305	0.00342	CcSEcCtD
Lidocaine—Haemoglobin—Fluorouracil—colon cancer	0.000305	0.00341	CcSEcCtD
Lidocaine—Rhinitis—Fluorouracil—colon cancer	0.000304	0.00341	CcSEcCtD
Lidocaine—Depressed level of consciousness—Methotrexate—colon cancer	0.000303	0.0034	CcSEcCtD
Lidocaine—Haemorrhage—Fluorouracil—colon cancer	0.000303	0.0034	CcSEcCtD
Lidocaine—Cardiac disorder—Vincristine—colon cancer	0.000302	0.00338	CcSEcCtD
Lidocaine—Hypoaesthesia—Fluorouracil—colon cancer	0.000302	0.00338	CcSEcCtD
Lidocaine—Skin exfoliation—Methotrexate—colon cancer	0.0003	0.00336	CcSEcCtD
Lidocaine—Angiopathy—Vincristine—colon cancer	0.000295	0.0033	CcSEcCtD
Lidocaine—Flushing—Irinotecan—colon cancer	0.000294	0.00329	CcSEcCtD
Lidocaine—Cardiac disorder—Irinotecan—colon cancer	0.000294	0.00329	CcSEcCtD
Lidocaine—CYP2A6—liver—colon cancer	0.000292	0.0202	CbGeAlD
Lidocaine—Urinary retention—Capecitabine—colon cancer	0.000291	0.00326	CcSEcCtD
Lidocaine—Cardiac arrest—Capecitabine—colon cancer	0.000291	0.00326	CcSEcCtD
Lidocaine—Angiopathy—Irinotecan—colon cancer	0.000287	0.00322	CcSEcCtD
Lidocaine—Coma—Methotrexate—colon cancer	0.000287	0.00322	CcSEcCtD
Lidocaine—Immune system disorder—Irinotecan—colon cancer	0.000286	0.0032	CcSEcCtD
Lidocaine—ABCB1—blood vessel—colon cancer	0.000285	0.0197	CbGeAlD
Lidocaine—Chills—Irinotecan—colon cancer	0.000284	0.00318	CcSEcCtD
Lidocaine—SLC22A5—renal system—colon cancer	0.000277	0.0191	CbGeAlD
Lidocaine—Back pain—Vincristine—colon cancer	0.000274	0.00307	CcSEcCtD
Lidocaine—CYP2C8—renal system—colon cancer	0.000269	0.0185	CbGeAlD
Lidocaine—Back pain—Irinotecan—colon cancer	0.000266	0.00299	CcSEcCtD
Lidocaine—Asthma—Capecitabine—colon cancer	0.000265	0.00297	CcSEcCtD
Lidocaine—Dysphagia—Capecitabine—colon cancer	0.000265	0.00297	CcSEcCtD
Lidocaine—Erythema—Fluorouracil—colon cancer	0.000264	0.00296	CcSEcCtD
Lidocaine—Bronchospasm—Capecitabine—colon cancer	0.00026	0.00292	CcSEcCtD
Lidocaine—Agitation—Vincristine—colon cancer	0.00026	0.00291	CcSEcCtD
Lidocaine—Sweating increased—Capecitabine—colon cancer	0.000258	0.00289	CcSEcCtD
Lidocaine—CYP1A2—renal system—colon cancer	0.000251	0.0173	CbGeAlD
Lidocaine—Vision blurred—Fluorouracil—colon cancer	0.000249	0.00279	CcSEcCtD
Lidocaine—SCN10A—lymph node—colon cancer	0.000246	0.017	CbGeAlD
Lidocaine—Convulsion—Vincristine—colon cancer	0.000245	0.00275	CcSEcCtD
Lidocaine—Hypertension—Vincristine—colon cancer	0.000244	0.00274	CcSEcCtD
Lidocaine—CYP3A5—renal system—colon cancer	0.000242	0.0167	CbGeAlD
Lidocaine—Loss of consciousness—Irinotecan—colon cancer	0.000242	0.00271	CcSEcCtD
Lidocaine—CYP2B6—renal system—colon cancer	0.000241	0.0166	CbGeAlD
Lidocaine—Visual disturbance—Methotrexate—colon cancer	0.000241	0.0027	CcSEcCtD
Lidocaine—Hypertension—Irinotecan—colon cancer	0.000238	0.00267	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Methotrexate—colon cancer	0.000235	0.00264	CcSEcCtD
Lidocaine—Neuropathy peripheral—Capecitabine—colon cancer	0.000231	0.00259	CcSEcCtD
Lidocaine—Anaphylactic shock—Vincristine—colon cancer	0.000231	0.00259	CcSEcCtD
Lidocaine—Oedema—Vincristine—colon cancer	0.000231	0.00259	CcSEcCtD
Lidocaine—Stomatitis—Capecitabine—colon cancer	0.00023	0.00258	CcSEcCtD
Lidocaine—Convulsion—Fluorouracil—colon cancer	0.000229	0.00256	CcSEcCtD
Lidocaine—Osteoarthritis—Methotrexate—colon cancer	0.000228	0.00255	CcSEcCtD
Lidocaine—SLC22A5—digestive system—colon cancer	0.000227	0.0157	CbGeAlD
Lidocaine—Confusional state—Irinotecan—colon cancer	0.000227	0.00254	CcSEcCtD
Lidocaine—Nervous system disorder—Vincristine—colon cancer	0.000226	0.00254	CcSEcCtD
Lidocaine—Anaphylactic shock—Irinotecan—colon cancer	0.000225	0.00252	CcSEcCtD
Lidocaine—Oedema—Irinotecan—colon cancer	0.000225	0.00252	CcSEcCtD
Lidocaine—Chest pain—Fluorouracil—colon cancer	0.000225	0.00252	CcSEcCtD
Lidocaine—SCN3A—lymph node—colon cancer	0.000224	0.0155	CbGeAlD
Lidocaine—Hyperhidrosis—Vincristine—colon cancer	0.000223	0.0025	CcSEcCtD
Lidocaine—Shock—Irinotecan—colon cancer	0.000221	0.00248	CcSEcCtD
Lidocaine—Nervous system disorder—Irinotecan—colon cancer	0.00022	0.00247	CcSEcCtD
Lidocaine—Hyperhidrosis—Irinotecan—colon cancer	0.000217	0.00244	CcSEcCtD
Lidocaine—Confusional state—Fluorouracil—colon cancer	0.000217	0.00243	CcSEcCtD
Lidocaine—Hypotension—Vincristine—colon cancer	0.000216	0.00242	CcSEcCtD
Lidocaine—Bradycardia—Capecitabine—colon cancer	0.000216	0.00242	CcSEcCtD
Lidocaine—Oedema—Fluorouracil—colon cancer	0.000215	0.00241	CcSEcCtD
Lidocaine—Anaphylactic shock—Fluorouracil—colon cancer	0.000215	0.00241	CcSEcCtD
Lidocaine—Haemoglobin—Capecitabine—colon cancer	0.000213	0.00239	CcSEcCtD
Lidocaine—Rhinitis—Capecitabine—colon cancer	0.000212	0.00238	CcSEcCtD
Lidocaine—Haemorrhage—Capecitabine—colon cancer	0.000212	0.00237	CcSEcCtD
Lidocaine—Nervous system disorder—Fluorouracil—colon cancer	0.000211	0.00237	CcSEcCtD
Lidocaine—Hypoaesthesia—Capecitabine—colon cancer	0.000211	0.00236	CcSEcCtD
Lidocaine—Hypotension—Irinotecan—colon cancer	0.00021	0.00235	CcSEcCtD
Lidocaine—Paraesthesia—Vincristine—colon cancer	0.000207	0.00232	CcSEcCtD
Lidocaine—CYP1A2—digestive system—colon cancer	0.000206	0.0142	CbGeAlD
Lidocaine—Visual impairment—Capecitabine—colon cancer	0.000204	0.00229	CcSEcCtD
Lidocaine—Paraesthesia—Irinotecan—colon cancer	0.000202	0.00226	CcSEcCtD
Lidocaine—Hypotension—Fluorouracil—colon cancer	0.000201	0.00226	CcSEcCtD
Lidocaine—SLC22A5—vagina—colon cancer	0.000201	0.0139	CbGeAlD
Lidocaine—Dyspnoea—Irinotecan—colon cancer	0.0002	0.00225	CcSEcCtD
Lidocaine—CYP2B6—lymphoid tissue—colon cancer	0.0002	0.0138	CbGeAlD
Lidocaine—Somnolence—Irinotecan—colon cancer	0.0002	0.00224	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Vincristine—colon cancer	0.000199	0.00223	CcSEcCtD
Lidocaine—CYP3A5—digestive system—colon cancer	0.000199	0.0137	CbGeAlD
Lidocaine—Eye disorder—Capecitabine—colon cancer	0.000198	0.00222	CcSEcCtD
Lidocaine—CYP2B6—digestive system—colon cancer	0.000198	0.0136	CbGeAlD
Lidocaine—Tinnitus—Capecitabine—colon cancer	0.000197	0.00221	CcSEcCtD
Lidocaine—Pain—Vincristine—colon cancer	0.000197	0.00221	CcSEcCtD
Lidocaine—Asthma—Methotrexate—colon cancer	0.000197	0.00221	CcSEcCtD
Lidocaine—Cardiac disorder—Capecitabine—colon cancer	0.000197	0.0022	CcSEcCtD
Lidocaine—Flushing—Capecitabine—colon cancer	0.000197	0.0022	CcSEcCtD
Lidocaine—CYP2C9—digestive system—colon cancer	0.000196	0.0135	CbGeAlD
Lidocaine—CYP2C8—vagina—colon cancer	0.000194	0.0134	CbGeAlD
Lidocaine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000194	0.00218	CcSEcCtD
Lidocaine—Paraesthesia—Fluorouracil—colon cancer	0.000193	0.00217	CcSEcCtD
Lidocaine—Pain—Irinotecan—colon cancer	0.000192	0.00215	CcSEcCtD
Lidocaine—Angiopathy—Capecitabine—colon cancer	0.000192	0.00215	CcSEcCtD
Lidocaine—Dyspnoea—Fluorouracil—colon cancer	0.000192	0.00215	CcSEcCtD
Lidocaine—Somnolence—Fluorouracil—colon cancer	0.000191	0.00215	CcSEcCtD
Lidocaine—Immune system disorder—Capecitabine—colon cancer	0.000191	0.00214	CcSEcCtD
Lidocaine—Chills—Capecitabine—colon cancer	0.00019	0.00213	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000186	0.00208	CcSEcCtD
Lidocaine—Feeling abnormal—Irinotecan—colon cancer	0.000185	0.00208	CcSEcCtD
Lidocaine—Erythema—Capecitabine—colon cancer	0.000184	0.00207	CcSEcCtD
Lidocaine—Pain—Fluorouracil—colon cancer	0.000184	0.00206	CcSEcCtD
Lidocaine—CYP3A4—renal system—colon cancer	0.000182	0.0125	CbGeAlD
Lidocaine—Dysgeusia—Capecitabine—colon cancer	0.000181	0.00202	CcSEcCtD
Lidocaine—CYP2D6—renal system—colon cancer	0.000179	0.0123	CbGeAlD
Lidocaine—Back pain—Capecitabine—colon cancer	0.000178	0.002	CcSEcCtD
Lidocaine—Feeling abnormal—Fluorouracil—colon cancer	0.000177	0.00199	CcSEcCtD
Lidocaine—Drowsiness—Methotrexate—colon cancer	0.000176	0.00197	CcSEcCtD
Lidocaine—CYP3A5—vagina—colon cancer	0.000176	0.0121	CbGeAlD
Lidocaine—CYP2B6—vagina—colon cancer	0.000174	0.012	CbGeAlD
Lidocaine—Vision blurred—Capecitabine—colon cancer	0.000174	0.00195	CcSEcCtD
Lidocaine—Tremor—Capecitabine—colon cancer	0.000173	0.00194	CcSEcCtD
Lidocaine—Stomatitis—Methotrexate—colon cancer	0.000171	0.00192	CcSEcCtD
Lidocaine—Urticaria—Fluorouracil—colon cancer	0.000171	0.00192	CcSEcCtD
Lidocaine—Hypersensitivity—Vincristine—colon cancer	0.00017	0.00191	CcSEcCtD
Lidocaine—ABCB1—embryo—colon cancer	0.00017	0.0117	CbGeAlD
Lidocaine—SLC22A5—liver—colon cancer	0.000169	0.0117	CbGeAlD
Lidocaine—Hypersensitivity—Irinotecan—colon cancer	0.000166	0.00186	CcSEcCtD
Lidocaine—Asthenia—Vincristine—colon cancer	0.000166	0.00186	CcSEcCtD
Lidocaine—CYP2C8—liver—colon cancer	0.000164	0.0113	CbGeAlD
Lidocaine—Loss of consciousness—Capecitabine—colon cancer	0.000162	0.00182	CcSEcCtD
Lidocaine—Asthenia—Irinotecan—colon cancer	0.000161	0.00181	CcSEcCtD
Lidocaine—Hypertension—Capecitabine—colon cancer	0.000159	0.00178	CcSEcCtD
Lidocaine—Hypersensitivity—Fluorouracil—colon cancer	0.000159	0.00178	CcSEcCtD
Lidocaine—Haemoglobin—Methotrexate—colon cancer	0.000158	0.00178	CcSEcCtD
Lidocaine—Haemorrhage—Methotrexate—colon cancer	0.000158	0.00177	CcSEcCtD
Lidocaine—Chest pain—Capecitabine—colon cancer	0.000157	0.00176	CcSEcCtD
Lidocaine—Anxiety—Capecitabine—colon cancer	0.000156	0.00175	CcSEcCtD
Lidocaine—CYP1A2—liver—colon cancer	0.000154	0.0106	CbGeAlD
Lidocaine—Dizziness—Vincristine—colon cancer	0.000153	0.00171	CcSEcCtD
Lidocaine—Visual impairment—Methotrexate—colon cancer	0.000152	0.0017	CcSEcCtD
Lidocaine—Confusional state—Capecitabine—colon cancer	0.000152	0.0017	CcSEcCtD
Lidocaine—Oedema—Capecitabine—colon cancer	0.00015	0.00169	CcSEcCtD
Lidocaine—CYP3A4—digestive system—colon cancer	0.000149	0.0103	CbGeAlD
Lidocaine—Dizziness—Irinotecan—colon cancer	0.000149	0.00167	CcSEcCtD
Lidocaine—CYP3A5—liver—colon cancer	0.000148	0.0102	CbGeAlD
Lidocaine—Shock—Capecitabine—colon cancer	0.000148	0.00166	CcSEcCtD
Lidocaine—Nervous system disorder—Capecitabine—colon cancer	0.000148	0.00165	CcSEcCtD
Lidocaine—Eye disorder—Methotrexate—colon cancer	0.000147	0.00165	CcSEcCtD
Lidocaine—CYP2B6—liver—colon cancer	0.000147	0.0102	CbGeAlD
Lidocaine—Tinnitus—Methotrexate—colon cancer	0.000147	0.00165	CcSEcCtD
Lidocaine—CYP2D6—digestive system—colon cancer	0.000147	0.0101	CbGeAlD
Lidocaine—Vomiting—Vincristine—colon cancer	0.000147	0.00165	CcSEcCtD
Lidocaine—Cardiac disorder—Methotrexate—colon cancer	0.000146	0.00164	CcSEcCtD
Lidocaine—CYP2C9—liver—colon cancer	0.000146	0.0101	CbGeAlD
Lidocaine—Rash—Vincristine—colon cancer	0.000146	0.00163	CcSEcCtD
Lidocaine—Hyperhidrosis—Capecitabine—colon cancer	0.000145	0.00163	CcSEcCtD
Lidocaine—Dermatitis—Vincristine—colon cancer	0.000145	0.00163	CcSEcCtD
Lidocaine—Headache—Vincristine—colon cancer	0.000145	0.00162	CcSEcCtD
Lidocaine—Angiopathy—Methotrexate—colon cancer	0.000143	0.0016	CcSEcCtD
Lidocaine—Vomiting—Irinotecan—colon cancer	0.000143	0.0016	CcSEcCtD
Lidocaine—Immune system disorder—Methotrexate—colon cancer	0.000142	0.0016	CcSEcCtD
Lidocaine—Dizziness—Fluorouracil—colon cancer	0.000142	0.0016	CcSEcCtD
Lidocaine—Rash—Irinotecan—colon cancer	0.000142	0.00159	CcSEcCtD
Lidocaine—Dermatitis—Irinotecan—colon cancer	0.000142	0.00159	CcSEcCtD
Lidocaine—Chills—Methotrexate—colon cancer	0.000141	0.00159	CcSEcCtD
Lidocaine—Headache—Irinotecan—colon cancer	0.000141	0.00158	CcSEcCtD
Lidocaine—Hypotension—Capecitabine—colon cancer	0.000141	0.00158	CcSEcCtD
Lidocaine—ABCB1—epithelium—colon cancer	0.000139	0.00957	CbGeAlD
Lidocaine—Erythema—Methotrexate—colon cancer	0.000137	0.00154	CcSEcCtD
Lidocaine—Nausea—Vincristine—colon cancer	0.000137	0.00154	CcSEcCtD
Lidocaine—Vomiting—Fluorouracil—colon cancer	0.000137	0.00153	CcSEcCtD
Lidocaine—Rash—Fluorouracil—colon cancer	0.000136	0.00152	CcSEcCtD
Lidocaine—Dermatitis—Fluorouracil—colon cancer	0.000136	0.00152	CcSEcCtD
Lidocaine—Paraesthesia—Capecitabine—colon cancer	0.000135	0.00151	CcSEcCtD
Lidocaine—Headache—Fluorouracil—colon cancer	0.000135	0.00151	CcSEcCtD
Lidocaine—Dysgeusia—Methotrexate—colon cancer	0.000134	0.00151	CcSEcCtD
Lidocaine—Dyspnoea—Capecitabine—colon cancer	0.000134	0.0015	CcSEcCtD
Lidocaine—Nausea—Irinotecan—colon cancer	0.000134	0.0015	CcSEcCtD
Lidocaine—Back pain—Methotrexate—colon cancer	0.000133	0.00149	CcSEcCtD
Lidocaine—SLC22A5—lymph node—colon cancer	0.00013	0.00896	CbGeAlD
Lidocaine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00013	0.00146	CcSEcCtD
Lidocaine—Vision blurred—Methotrexate—colon cancer	0.000129	0.00145	CcSEcCtD
Lidocaine—ABCB1—renal system—colon cancer	0.000129	0.00888	CbGeAlD
Lidocaine—Pain—Capecitabine—colon cancer	0.000129	0.00144	CcSEcCtD
Lidocaine—Nausea—Fluorouracil—colon cancer	0.000128	0.00143	CcSEcCtD
Lidocaine—Feeling abnormal—Capecitabine—colon cancer	0.000124	0.00139	CcSEcCtD
Lidocaine—Urticaria—Capecitabine—colon cancer	0.00012	0.00134	CcSEcCtD
Lidocaine—Convulsion—Methotrexate—colon cancer	0.000119	0.00133	CcSEcCtD
Lidocaine—Chest pain—Methotrexate—colon cancer	0.000117	0.00131	CcSEcCtD
Lidocaine—Confusional state—Methotrexate—colon cancer	0.000113	0.00127	CcSEcCtD
Lidocaine—Anaphylactic shock—Methotrexate—colon cancer	0.000112	0.00126	CcSEcCtD
Lidocaine—CYP3A4—liver—colon cancer	0.000111	0.00767	CbGeAlD
Lidocaine—Hypersensitivity—Capecitabine—colon cancer	0.000111	0.00124	CcSEcCtD
Lidocaine—Nervous system disorder—Methotrexate—colon cancer	0.00011	0.00123	CcSEcCtD
Lidocaine—CYP2D6—liver—colon cancer	0.000109	0.00754	CbGeAlD
Lidocaine—Hyperhidrosis—Methotrexate—colon cancer	0.000108	0.00121	CcSEcCtD
Lidocaine—Asthenia—Capecitabine—colon cancer	0.000108	0.00121	CcSEcCtD
Lidocaine—ABCB1—lymphoid tissue—colon cancer	0.000107	0.00737	CbGeAlD
Lidocaine—ABCB1—digestive system—colon cancer	0.000106	0.00728	CbGeAlD
Lidocaine—Hypotension—Methotrexate—colon cancer	0.000105	0.00117	CcSEcCtD
Lidocaine—Paraesthesia—Methotrexate—colon cancer	0.000101	0.00113	CcSEcCtD
Lidocaine—Dyspnoea—Methotrexate—colon cancer	9.99e-05	0.00112	CcSEcCtD
Lidocaine—Somnolence—Methotrexate—colon cancer	9.96e-05	0.00112	CcSEcCtD
Lidocaine—Dizziness—Capecitabine—colon cancer	9.95e-05	0.00112	CcSEcCtD
Lidocaine—ABCB1—bone marrow—colon cancer	9.73e-05	0.00671	CbGeAlD
Lidocaine—Gastrointestinal disorder—Methotrexate—colon cancer	9.67e-05	0.00108	CcSEcCtD
Lidocaine—Pain—Methotrexate—colon cancer	9.58e-05	0.00107	CcSEcCtD
Lidocaine—Vomiting—Capecitabine—colon cancer	9.57e-05	0.00107	CcSEcCtD
Lidocaine—Rash—Capecitabine—colon cancer	9.49e-05	0.00106	CcSEcCtD
Lidocaine—Dermatitis—Capecitabine—colon cancer	9.48e-05	0.00106	CcSEcCtD
Lidocaine—Headache—Capecitabine—colon cancer	9.43e-05	0.00106	CcSEcCtD
Lidocaine—ABCB1—vagina—colon cancer	9.32e-05	0.00643	CbGeAlD
Lidocaine—Feeling abnormal—Methotrexate—colon cancer	9.23e-05	0.00103	CcSEcCtD
Lidocaine—Nausea—Capecitabine—colon cancer	8.94e-05	0.001	CcSEcCtD
Lidocaine—Urticaria—Methotrexate—colon cancer	8.9e-05	0.000997	CcSEcCtD
Lidocaine—Hypersensitivity—Methotrexate—colon cancer	8.25e-05	0.000925	CcSEcCtD
Lidocaine—Asthenia—Methotrexate—colon cancer	8.04e-05	0.000901	CcSEcCtD
Lidocaine—ABCB1—liver—colon cancer	7.87e-05	0.00543	CbGeAlD
Lidocaine—Dizziness—Methotrexate—colon cancer	7.41e-05	0.00083	CcSEcCtD
Lidocaine—Vomiting—Methotrexate—colon cancer	7.12e-05	0.000798	CcSEcCtD
Lidocaine—Rash—Methotrexate—colon cancer	7.06e-05	0.000792	CcSEcCtD
Lidocaine—Dermatitis—Methotrexate—colon cancer	7.06e-05	0.000791	CcSEcCtD
Lidocaine—Headache—Methotrexate—colon cancer	7.02e-05	0.000787	CcSEcCtD
Lidocaine—Nausea—Methotrexate—colon cancer	6.65e-05	0.000746	CcSEcCtD
Lidocaine—ABCB1—lymph node—colon cancer	6.03e-05	0.00416	CbGeAlD
Lidocaine—CYP2C9—Metabolism—CHST5—colon cancer	2.28e-05	0.000454	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—PIK3CA—colon cancer	2.28e-05	0.000453	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—HRAS—colon cancer	2.28e-05	0.000453	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—HRAS—colon cancer	2.28e-05	0.000453	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—colon cancer	2.28e-05	0.000453	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—AKT1—colon cancer	2.27e-05	0.000452	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—HRAS—colon cancer	2.26e-05	0.000449	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—HRAS—colon cancer	2.26e-05	0.000449	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—HRAS—colon cancer	2.26e-05	0.000449	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	2.24e-05	0.000446	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—PPARG—colon cancer	2.24e-05	0.000445	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—HRAS—colon cancer	2.24e-05	0.000445	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EP300—colon cancer	2.24e-05	0.000445	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.24e-05	0.000445	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—FGFR3—colon cancer	2.23e-05	0.000444	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—HRAS—colon cancer	2.23e-05	0.000443	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—SRC—colon cancer	2.21e-05	0.000439	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	2.18e-05	0.000434	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—HRAS—colon cancer	2.18e-05	0.000433	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—SRC—colon cancer	2.18e-05	0.000433	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—AKT1—colon cancer	2.17e-05	0.000432	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—AKT1—colon cancer	2.17e-05	0.000432	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—AKT1—colon cancer	2.16e-05	0.00043	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—AKT1—colon cancer	2.16e-05	0.00043	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—HRAS—colon cancer	2.15e-05	0.000428	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—AKT1—colon cancer	2.15e-05	0.000427	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—HRAS—colon cancer	2.15e-05	0.000427	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—FGFR3—colon cancer	2.14e-05	0.000426	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—AKT1—colon cancer	2.14e-05	0.000425	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—NRAS—colon cancer	2.12e-05	0.000422	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—VEGFA—colon cancer	2.12e-05	0.000421	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—HRAS—colon cancer	2.11e-05	0.000419	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	2.11e-05	0.000419	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—colon cancer	2.11e-05	0.000419	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—AKT1—colon cancer	2.1e-05	0.000417	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—NRAS—colon cancer	2.09e-05	0.000416	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—AKT1—colon cancer	2.08e-05	0.000413	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	2.02e-05	0.000401	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—colon cancer	2.01e-05	0.0004	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—AKT1—colon cancer	2.01e-05	0.0004	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—AKT1—colon cancer	2.01e-05	0.0004	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—SRC—colon cancer	2e-05	0.000397	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—AKT1—colon cancer	2e-05	0.000397	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—AKT1—colon cancer	2e-05	0.000397	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—AKT1—colon cancer	1.99e-05	0.000397	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—AKT1—colon cancer	1.98e-05	0.000393	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—AKT1—colon cancer	1.97e-05	0.000391	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CHST5—colon cancer	1.95e-05	0.000388	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ODC1—colon cancer	1.95e-05	0.000388	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	1.95e-05	0.000388	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TGFB1—colon cancer	1.95e-05	0.000387	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—VEGFA—colon cancer	1.94e-05	0.000387	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—AKT1—colon cancer	1.92e-05	0.000383	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—NRAS—colon cancer	1.92e-05	0.000382	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—colon cancer	1.91e-05	0.000379	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.9e-05	0.000378	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—AKT1—colon cancer	1.9e-05	0.000378	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.89e-05	0.000377	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—AKT1—colon cancer	1.86e-05	0.00037	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—KRAS—colon cancer	1.83e-05	0.000363	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDH1—colon cancer	1.81e-05	0.00036	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—KRAS—colon cancer	1.8e-05	0.000358	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	1.78e-05	0.000354	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ABCB1—colon cancer	1.78e-05	0.000354	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.77e-05	0.000351	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—TYMS—colon cancer	1.75e-05	0.000348	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.72e-05	0.000342	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.7e-05	0.000338	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—PIK3CA—colon cancer	1.68e-05	0.000334	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.66e-05	0.000331	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—KRAS—colon cancer	1.65e-05	0.000329	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD8A—colon cancer	1.59e-05	0.000316	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.58e-05	0.000315	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CTNNB1—colon cancer	1.58e-05	0.000313	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—HRAS—colon cancer	1.55e-05	0.000309	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.54e-05	0.000306	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HRAS—colon cancer	1.53e-05	0.000305	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CHST5—colon cancer	1.51e-05	0.0003	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ODC1—colon cancer	1.51e-05	0.0003	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.5e-05	0.000298	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—EP300—colon cancer	1.47e-05	0.000291	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—SRC—colon cancer	1.42e-05	0.000283	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—HRAS—colon cancer	1.41e-05	0.000279	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CTNNB1—colon cancer	1.39e-05	0.000277	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—VEGFA—colon cancer	1.39e-05	0.000276	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.38e-05	0.000274	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.38e-05	0.000273	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—AKT1—colon cancer	1.37e-05	0.000273	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—NRAS—colon cancer	1.37e-05	0.000273	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CDKN1A—colon cancer	1.36e-05	0.00027	CbGpPWpGaD
Lidocaine—EGFR—Immune System—BCL2L1—colon cancer	1.36e-05	0.00027	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—AKT1—colon cancer	1.35e-05	0.000269	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.35e-05	0.000268	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDKN1A—colon cancer	1.31e-05	0.00026	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FGFR3—colon cancer	1.3e-05	0.000259	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—EP300—colon cancer	1.29e-05	0.000257	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TGFB1—colon cancer	1.27e-05	0.000253	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.27e-05	0.000253	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—SRC—colon cancer	1.26e-05	0.00025	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PPARG—colon cancer	1.24e-05	0.000247	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—NRAS—colon cancer	1.21e-05	0.000241	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—SRC—colon cancer	1.21e-05	0.00024	CbGpPWpGaD
Lidocaine—EGFR—Disease—FGFR3—colon cancer	1.2e-05	0.000239	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ABCB1—colon cancer	1.18e-05	0.000236	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—KRAS—colon cancer	1.18e-05	0.000235	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.17e-05	0.000233	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—TYMS—colon cancer	1.16e-05	0.000231	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—NRAS—colon cancer	1.16e-05	0.000231	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.16e-05	0.00023	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.13e-05	0.000225	CbGpPWpGaD
Lidocaine—EGFR—Disease—APC—colon cancer	1.1e-05	0.000219	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDH1—colon cancer	1.1e-05	0.000218	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ABCB1—colon cancer	1.09e-05	0.000216	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—TYMS—colon cancer	1.07e-05	0.000212	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—KRAS—colon cancer	1.04e-05	0.000207	CbGpPWpGaD
Lidocaine—EGFR—Disease—BRAF—colon cancer	1.04e-05	0.000206	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HRAS—colon cancer	1e-05	0.000199	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KRAS—colon cancer	1e-05	0.000199	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTGS2—colon cancer	9.75e-06	0.000194	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PIK3CA—colon cancer	9.57e-06	0.00019	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	9.56e-06	0.00019	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.43e-06	0.000188	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PIK3CA—colon cancer	9.19e-06	0.000183	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.12e-06	0.000181	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—HRAS—colon cancer	8.86e-06	0.000176	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—AKT1—colon cancer	8.86e-06	0.000176	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ABCB1—colon cancer	8.76e-06	0.000174	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—TYMS—colon cancer	8.61e-06	0.000171	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ABCB1—colon cancer	8.56e-06	0.00017	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HRAS—colon cancer	8.51e-06	0.000169	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—TYMS—colon cancer	8.41e-06	0.000167	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGFR3—colon cancer	8.41e-06	0.000167	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTGS2—colon cancer	8.37e-06	0.000166	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PPARG—colon cancer	8.24e-06	0.000164	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—EP300—colon cancer	8.11e-06	0.000161	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CTNNB1—colon cancer	8.11e-06	0.000161	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.06e-06	0.00016	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDKN1A—colon cancer	7.92e-06	0.000158	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—AKT1—colon cancer	7.82e-06	0.000156	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—APC—colon cancer	7.72e-06	0.000153	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—NRAS—colon cancer	7.72e-06	0.000153	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.58e-06	0.000151	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PPARG—colon cancer	7.56e-06	0.00015	CbGpPWpGaD
Lidocaine—EGFR—Immune System—EP300—colon cancer	7.54e-06	0.00015	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—AKT1—colon cancer	7.51e-06	0.000149	CbGpPWpGaD
Lidocaine—EGFR—Disease—CTNNB1—colon cancer	7.49e-06	0.000149	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.42e-06	0.000148	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ABCB1—colon cancer	7.42e-06	0.000148	CbGpPWpGaD
Lidocaine—EGFR—Immune System—SRC—colon cancer	7.33e-06	0.000146	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN1A—colon cancer	7.31e-06	0.000145	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—TYMS—colon cancer	7.29e-06	0.000145	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—BRAF—colon cancer	7.25e-06	0.000144	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NRAS—colon cancer	7.05e-06	0.00014	CbGpPWpGaD
Lidocaine—EGFR—Disease—EP300—colon cancer	6.96e-06	0.000138	CbGpPWpGaD
Lidocaine—EGFR—Disease—SRC—colon cancer	6.77e-06	0.000135	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KRAS—colon cancer	6.64e-06	0.000132	CbGpPWpGaD
Lidocaine—EGFR—Disease—NRAS—colon cancer	6.51e-06	0.000129	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—colon cancer	6.48e-06	0.000129	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—TYMS—colon cancer	6.35e-06	0.000126	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.34e-06	0.000126	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.17e-06	0.000123	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PIK3CA—colon cancer	6.1e-06	0.000121	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PPARG—colon cancer	6.1e-06	0.000121	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCB1—colon cancer	6.09e-06	0.000121	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KRAS—colon cancer	6.07e-06	0.000121	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—colon cancer	6.06e-06	0.000121	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—colon cancer	6.05e-06	0.00012	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCB1—colon cancer	6.04e-06	0.00012	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PIK3CA—colon cancer	6e-06	0.000119	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—TYMS—colon cancer	5.98e-06	0.000119	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PPARG—colon cancer	5.96e-06	0.000118	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—colon cancer	5.94e-06	0.000118	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—TYMS—colon cancer	5.93e-06	0.000118	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—colon cancer	5.65e-06	0.000112	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.61e-06	0.000112	CbGpPWpGaD
Lidocaine—EGFR—Disease—KRAS—colon cancer	5.6e-06	0.000111	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PIK3CA—colon cancer	5.58e-06	0.000111	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CASP3—colon cancer	5.44e-06	0.000108	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—EP300—colon cancer	5.39e-06	0.000107	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—colon cancer	5.29e-06	0.000105	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.27e-06	0.000105	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CTNNB1—colon cancer	5.24e-06	0.000104	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PPARG—colon cancer	5.16e-06	0.000103	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCB1—colon cancer	5.16e-06	0.000103	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—colon cancer	5.16e-06	0.000103	CbGpPWpGaD
Lidocaine—EGFR—Disease—PIK3CA—colon cancer	5.15e-06	0.000102	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1A—colon cancer	5.12e-06	0.000102	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—TYMS—colon cancer	5.07e-06	0.000101	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—colon cancer	4.99e-06	9.91e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—EP300—colon cancer	4.94e-06	9.83e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—colon cancer	4.9e-06	9.75e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EP300—colon cancer	4.87e-06	9.69e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—colon cancer	4.8e-06	9.54e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—colon cancer	4.76e-06	9.47e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SRC—colon cancer	4.74e-06	9.42e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—colon cancer	4.69e-06	9.32e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—colon cancer	4.62e-06	9.18e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.56e-06	9.08e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NRAS—colon cancer	4.56e-06	9.07e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—colon cancer	4.56e-06	9.06e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PPARG—colon cancer	4.5e-06	8.94e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—colon cancer	4.25e-06	8.44e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PPARG—colon cancer	4.24e-06	8.42e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—colon cancer	4.24e-06	8.42e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—colon cancer	4.21e-06	8.36e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PPARG—colon cancer	4.2e-06	8.35e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—colon cancer	4.06e-06	8.07e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CA—colon cancer	3.99e-06	7.93e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—EP300—colon cancer	3.99e-06	7.93e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCB1—colon cancer	3.98e-06	7.92e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KRAS—colon cancer	3.92e-06	7.8e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—TYMS—colon cancer	3.91e-06	7.78e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.9e-06	7.76e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—EP300—colon cancer	3.9e-06	7.75e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CA—colon cancer	3.66e-06	7.27e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CA—colon cancer	3.61e-06	7.17e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPARG—colon cancer	3.59e-06	7.14e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—colon cancer	3.54e-06	7.03e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—colon cancer	3.49e-06	6.93e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—EP300—colon cancer	3.38e-06	6.71e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—colon cancer	3.34e-06	6.63e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—colon cancer	3.33e-06	6.63e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—colon cancer	3.3e-06	6.57e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—colon cancer	3.26e-06	6.48e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—colon cancer	2.99e-06	5.94e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CA—colon cancer	2.95e-06	5.87e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—colon cancer	2.95e-06	5.86e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—EP300—colon cancer	2.94e-06	5.85e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CA—colon cancer	2.88e-06	5.73e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—colon cancer	2.82e-06	5.61e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—EP300—colon cancer	2.77e-06	5.51e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPARG—colon cancer	2.77e-06	5.51e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—EP300—colon cancer	2.75e-06	5.46e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CA—colon cancer	2.5e-06	4.97e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—colon cancer	2.41e-06	4.79e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—colon cancer	2.36e-06	4.68e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—EP300—colon cancer	2.35e-06	4.67e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—colon cancer	2.18e-06	4.33e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CA—colon cancer	2.18e-06	4.33e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CA—colon cancer	2.05e-06	4.08e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—colon cancer	2.04e-06	4.06e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CA—colon cancer	2.03e-06	4.04e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—EP300—colon cancer	1.81e-06	3.6e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—colon cancer	1.78e-06	3.53e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CA—colon cancer	1.74e-06	3.45e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—colon cancer	1.68e-06	3.33e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—colon cancer	1.66e-06	3.3e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—colon cancer	1.42e-06	2.82e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CA—colon cancer	1.34e-06	2.67e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—colon cancer	1.1e-06	2.18e-05	CbGpPWpGaD
